Conference Coverage

Study Characterizes Spectrum of Somatic Mutations in Chronic Lymphocytic Leukemia


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

This study was supported by grants from the National Institutes of Health, the National Cancer Institute, the Melton and Rosenbach Funds, the Blavatnik Family Foundation, the Howard Hughes Medical Institute (via an Early Career Physician-Scientist Award), and the Damon Runyon Cancer Research Foundation. Dr. Wang said she had no relevant financial disclosures. Some of the coauthors said they were consultants to numerous pharmaceutical companies or owned stock in pharmaceutical companies. Other than employment by INSERM on the part of Dr. Bernard, neither he nor Dr. Ebert had any relevant financial disclosures to report.

Pages

Recommended Reading

Panel Endorses Surveillance for Low-Risk Prostate Cancer
MDedge Internal Medicine
Medicare Study Confirms Colonoscopy's Cancer Prevention Power
MDedge Internal Medicine
ZO-FAST: Immediate Zoledronic Acid Beats Delayed Tx in Early Breast Cancer
MDedge Internal Medicine
AVEREL: Avastin Defers Progression in HER2-Positive Metastatic Breast Cancer*
MDedge Internal Medicine
Breast Cancer Vaccine Begins Phase III Trial
MDedge Internal Medicine
Contralateral Prophylactic Mastectomy Ups Surgical Risk
MDedge Internal Medicine
Multiparametric Magnetic Resonance Imaging Identifies Candidates for Prostate Cancer Surveillance
MDedge Internal Medicine
Gene Therapy Overrides Clotting Defect in Hemophilia B
MDedge Internal Medicine
Early Thrombolysis Improves Long-term Outcomes After DVT
MDedge Internal Medicine
Stem Cell Transplant: Physical, Mental Health Burdens Persist
MDedge Internal Medicine